Precigen
PGEN
$1.41
Share price
0.71%
Change (1 day)
16.53%
Change (1 year)
Categories
Precigen (PGEN) - Net assets
Net assets on the balance sheet as of December 2023 : $0.11 B
According to Precigen's latest financial reports the company has $0.11 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Precigen - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 17.62% |
| 2021-12-31 | $0.10 B | 59.81% |
| 2020-12-31 | $67.17 M | -6.33% |
| 2019-12-31 | $71.71 M | -81.07% |
| 2018-12-31 | $0.37 B | -30.71% |
| 2017-12-31 | $0.54 B | -3.99% |
| 2016-12-31 | $0.56 B | -19.24% |
| 2015-12-31 | $0.70 B | 72.22% |
| 2014-12-31 | $0.40 B | 7.33% |
| 2013-12-31 | $0.38 B | -218.59% |
| 2012-12-31 | $-0.33 B | 45.33% |
| 2011-12-31 | $-0.23 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $6.18 M | -94.78% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $80.25 M | -32.27% | 🇬🇧 UK |
 Novavax NVAX | -$0.72 B | -705.01% | 🇺🇸 USA |
 Novocure
NVCR | $0.36 B | 205.91% | Jersey |